EMR
February 7, 2024 - AI Summary
Overvalued by 70.5% based on the discounted cash flow analysis.
Market cap | $63.45 Billion |
---|---|
Enterprise Value | $71.90 Billion |
Dividend Yield | $2.0796 (1.88%) |
Earnings per Share | $18.7 |
Beta | 0.86 |
Outstanding Shares | 572,100,000 |
Avg 30 Day Volume | 3,129,830 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 5.91 |
---|---|
PEG | -16.09 |
Price to Sales | 4.01 |
Price to Book Ratio | 3.12 |
Enterprise Value to Revenue | 4.35 |
Enterprise Value to EBIT | 29.06 |
Enterprise Value to Net Income | 6 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.52 |
No data
No data